Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_assertion description "[Liver disease progression is accompanied by a proportional, drastic reduction in the magnitude of reversible inhibitory drug interactions due to decreased hepatic uptake of the inhibitor and reduced CYP expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_assertion evidence source_evidence_literature NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_assertion SIO_000772 20604736 NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_assertion wasDerivedFrom befree-20150227 NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_assertion wasGeneratedBy ECO_0000203 NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP820785.RAGKiBgAIXZnAjjcSYgY-zais-fZkC5ZD1YIRL4N5W2tQ130_provenance.